Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy
Publication year
2018Source
Leukemia, 32, 2, (2018), pp. 353-363ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Pathology
Journal title
Leukemia
Volume
vol. 32
Issue
iss. 2
Page start
p. 353
Page end
p. 363
Subject
Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life Sciences; Radboud University Medical CenterThis item appears in the following Collection(s)
- Academic publications [245186]
- Electronic publications [132486]
- Faculty of Medical Sciences [93207]
- Open Access publications [106066]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.